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ABSTRACT
Objective: To evaluate the effectiveness of enteral nutritional therapy (ENT) in the 
healing process of pressure ulcers (PU) in adults and the elderly. Method: A systematic 
review whose studies were identified through the databases of Cochrane, MEDLINE/
PubMed, SciELO, LILACS, EMBASE, CINAHL, Web of Science, and manual searches. 
It included randomized clinical trials (RCTs) without delimiting the period or language 
of publication, which addressed adults and elderly patients with pressure ulcers in a 
comparative treatment of enteral nutritional therapy and placebo or between enteral 
nutritional therapy with different compositions and dosages. Results: We included ten 
studies that considered different interventions. It resulted in more pressure ulcers healed 
in the groups that received the intervention. The included studies were heterogeneous 
with regard to patients, the type of intervention, the sample and the follow-up period, all 
of which made meta-analysis impossible. Conclusion: Although the enteral nutritional 
therapy demonstrates a promotion of pressure ulcer healing, sufficient evidence to 
confirm the hypothesis was not found.
DESCRIPTORS
Pressure Ulcer; Nutrition Therapy; Wound Healing; Review.
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INTRODUCTION
A pressure ulcer (PU) is a public health problem that 
affects sick people, the family and society. It is defined as 
"a damaged area located on the skin and underlying tissue 
caused by pressure, shear, friction, or a combination of(1)". Its 
etiology has other contributing factors that are intrinsic to 
the subject such as nutrition, age, and comorbidities, among 
others(2). Interventions imposed for its prevention and treat-
ment interfere in health care quality(3).
Age is considered a risk factor for PU, especially in pa-
tients aged 65 years or more. Failure of wound healing af-
fects three to six million people at that age, and represents 
85% of this occurrence(4).
In Brazil, the concern with the PU became more evident 
with the publication of RDC Nº 36, from July 25th 2013, 
which instituted actions to promote patient safety and qual-
ity improvement in health services. Prevention of PU was 
included in the patient safety plan for which strategies and 
actions for risk management must be developed(5). A pro-
tocol was published for prevention that includes strategies 
for optimization of nutrition and hydration(6).
Regarding nutrition, studies show a relationship be-
tween malnutrition and development of PU and delayed 
healing(7-8). A study that classified patients as malnour-
ished, at nutritional risk and well-nourished according 
to the Body Mass Index, found extremely poor nutri-
tional status in patients with PU (39.5% malnourished 
and 2.5% well-nourished), compared to patients without 
PU (16.6% malnourished and 23.6% well-nourished) (p 
<0.001)(9). A prospective study of high-risk and hospital-
ized patients identified malnutrition in 29% of patients 
upon admission and after four weeks 17% of these de-
veloped PU, however, the injury occurred in only 9% of 
patients who were not malnourished(10).
In this sense, nutritional triage contributes to identify-
ing the need for Enteral Nutrition Therapy (ENT) in or-
der to provide calories, proteins, amino acids, vitamins and 
proper hydration for patients with PU. The nurse should be 
the one responsible for carrying out the nutritional triage 
and actions for implementing ENT(11-13).
ENT uses specially formulated food (industrialized or 
not), exclusively or partially employed to replace or supple-
ment the alimentation for the nutritional needs of the pa-
tient, and is engaged in the synthesis or maintenance of 
tissues, organs or systems(5,11).
In order to prevent and treat PUs, many supplements 
were commercially developed for ENT (oral nutritional 
supplement and via nasogastric, nasoenteral/nasojejunal or 
percutaneous tube). These formulas are composed mainly 
of protein, arginine, glutamine, vitamin C, zinc, iron and 
vitamin E(14), and are classified according to the complexity 
of the nutrients in polymeric, oligomeric, and monomeric 
formulas, and also modular diets(15).
Regarding the importance of adequate nutritional status 
for PU healing, it is necessary to evaluate the effectiveness 
of Nutritional Therapy (NT) as a treatment for PU. For 
both, research with the appropriate design on the theme 
as well as systematic reviews for presenting the best level 
of evidence for clinical decision making is indispensable.
A systematic review (SR) published in 2003 aimed at 
evaluating the effectiveness of enteral and parenteral nu-
trition for the prevention and treatment of PU included 
eight randomized controlled trials (RCTs), and noted that 
nutritional supplements reduced the number of new ulcers, 
but it was not possible to reach definitive conclusions about 
the effect of enteral and parenteral nutrition due to the het-
erogeneity of the studies(16).
In another SR published in 2005 to verify the impact of 
enteral nutritional support on the incidence and healing of 
PUs, 15 studies were included and five were grouped into a 
meta-analysis of oral nutritional supplements or enteral tube 
feeding. The meta-analysis, n=1.224, of post-surgical chron-
ically-hospitalized elderly patients showed that oral supple-
ments were associated with a lower incidence of developing 
PU (odds ratio 0.75, 95% CI [62-89]). As for wound healing, 
meta-analysis was not possible, however individual studies 
have shown favorable results with the use of high doses of 
protein supplements specialized for PU healing(17).
In 2008, an SR evaluating treatments available for PU 
nutritional interventions included seven RCTs and the au-
thors found that the protein supplementation promoted the 
healing of ulcers compared with placebo (Scale Healing av-
erage score 3.55 [4.66] vs. 3.22 [4:11], p <0.05), but there 
is little evidence to justify routine use of ENT compared to 
the standard treatment for PU healing(18).
While there have been SRs conducted involving nutrition 
in the prevention and treatment of PU, it was found that 
these were not restricted to ENT; extrapolating the research 
to other strategies and this does not achieve a wide search 
in the databases. Therefore, considering the urgency of new 
studies with methodological quality and that the SR makes 
it possible to obtain answers to clinical questions and safely 
incorporate new procedures to professional practice with sci-
entific support(19), a SR aimed at evaluating the effectiveness 
of Enteral Nutrition Therapy (ENT) in the healing process of 
Pressure Ulcers (PU) in adults and the elderly was proposed.
METHOD
It is a Systematic Review (SR), based on the Cochrane 
Handbook for Systematic Reviews of the recommendations of In-
terventions proposed by the Cochrane Collaboration(20). The SR 
differs from other review methods because it uses explicit pro-
cedures of systematic search and critical analysis to synthesize 
the literature on a particular issue, aiming to minimize biases 
and random error present in individual analyzes(19).
To elaborate the research question, the acronym PI-
CO(20) was employed (P - population and problem; I - in-
tervention; C - comparison; O - outcomes) in which: P - 
Adults and the elderly with pressure ulcers; I - use of enteral 
nutritional therapy; C - Comparison without complement; 
or different formulas; O - Complete healing; Partial heal-
ing; Stability of the total area; reduction of exudate; reduc-
tion of devitalized tissues; treatment time for healing of 
pressure ulcers; and others. Thus, the research question was, 
“What is the effectiveness of enteral nutrition therapy in the PU 
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Manager version 5.1.0 program, in which the studies were 
judged as 'low risk of bias,' 'high risk bias' and 'uncertain/
unclear risk of bias' to six domains/areas: random sequence 
generation, allocation concealment, blinding of participants 
and personnel, blinding of outcome assessment, incomplete 
outcome data and selective outcome (20).
Due to the heterogeneity of the studies, the data were 
descriptively grouped and analyzed for outcomes.
There was no conflict of interest in conducting this re-
view, nor was any funding provided for the study.
RESULTS
432 studies were identified, of which 66 were in MED-
LINE/PUBMED, 100 in EMBASE, 58 in CENTRAL, 
124 in Web of Science, 69 in CINAHL, zero/none in Sci-
ELO or LILACS, and 15 in the manual search. Of these, 
156 were duplicates and 244 did not meet the inclusion 
criteria. Thus, we evaluated 32 studies in full, and after an 
independent review by two reviewers, ten studies were in-
cluded in this review, as shown in Figure 2. The opinion of 
the third reviewer for consensus of the included studies was 
requested. The Kappa index showed significant agreement 
0.939 (p <0.001 and 95% CI).
In the assessment of methodological quality of the stud-
ies, only two had low risk of bias for all assessed areas (E32, 
E90) and one for five areas (E5). Two classified with two 
areas as high risk of bias (E419, E424) and two with one 
(E420, E10). In eight studies there were at least one clas-
sified area in uncertain risk of bias (E5, E10, E412, E418: 
E419, E424, E425, E426), which shows a lack of detail in 
the description of the methodology of these studies and 
prevents a proper analysis as to quality. Figure 2 gives a 
review of studies for each area individually.
healing process in adults and the elderly?”
Inclusion criteria were randomized controlled trials 
without language restriction or publication date which eval-
uated the effect of ENT in the PU healing process in adults 
and elderly, hospitalized or at home, comparing treatment 
with ENT and placebo; ENT or of different compositions; 
or ENT with different dosages.
We excluded studies that involved other causes of 
wounds; were not limited to their ENT intervention (ad-
opted another route of administration); or did not describe 
the formula used in ENT.
The primary endpoint was the overall healing of PU, 
and the secondary endpoints were partial healing of PU; 
stability of the area; reduction of exudate and devitalized 
tissue. The search took place from May to August 2013. 
The studies were identified through the following databases: 
Cochrane Central Register of Controlled Trials (CENTRAL) 
in The Cochrane Library, National Library of Medicine/NLM 
(MEDLINE)/PubMed, Scientific Electronic Library online 
(SciELO), Latin American and Caribbean Health Sciences 
(LILACS), Biomedical Database (EMBASE), Cumulative 
Index to Nursing and Allied Health Literature (CINAHL) 
and Web of Science. The procedure also included a manual 
search through consulting summaries of papers presented 
at conferences, reference articles and systematic reviews of 
identified RCTs, ECR registration databases and contact 
with researchers active in wound treatment area.
The search strategies were formulated according to the 
criteria and documentation for each database. We used 
Medical Subject Heading (MeSH) descriptors, descriptors 
in Health Sciences (MeSH), and terms related to the re-
search problem (pressure ulcers), intervention (enteral nu-
trition therapy) and study design (randomized controlled 
trial), combined with boolean operators (AND and OR) 
and truncation symbols.
Chart 1 shows the search strategy adopted in the 
MEDLINE via PubMed, which was adapted for the other 
analyzed databases.
For inclusion, the abstracts of the identified studies 
were blindly and independently assessed by two reviewers 
who applied the eligibility criteria and selected the relevant 
studies; in case of disagreement, a third reviewer was re-
quested. In the first consensus meeting the selected studies 
were evaluated in full with application of eligibility criteria; 
and then in the second consensus meeting, the studies to 
be included and excluded from the review were defined. 
The degree of agreement between reviewers was assessed 
by measuring Kappa(20) using the STATA® 9.7 software. The 
Kappa assesses the interobserver agreement and ranges from 
1 (complete agreement) to -1 (complete disagreement)(21).
For data extraction, a form(22) was adopted which in-
cluded: identification of the study (title, journal, year of 
publication, volume and number), method, characteristics 
of participants and intervention, outcome, ethical aspects, 
financing and opinion of the reviewer.
The methodological quality of the studies was per-
formed using the Cochrane Collaboration tool for assessing the 
risk of bias in randomized clinical trials available in Review 
Chart 1 - Search strategy in MEDLINE/PubMed database - Curi-
tiba, PR, 2013. 
#1 (((((((((“Pressure Ulcer”[MeSH Terms] OR Pressure Ulcers[Title/
Abstract]) OR Ulcers, Pressure[Title/Abstract]) OR Bedsore[Title/
Abstract]) OR Bedsores[Title/Abstract]) OR Pressure Sore[Title/
Abstract]) OR Pressure Sores[Title/Abstract]) OR Bed Sores[Title/
Abstract]) OR Bed Sore[Title/Abstract]) OR Decubitus Ulcer[Title/
Abstract]) OR Decubitus Ulcers[Title/Abstract]
#2 “Diet Therapy”[MeSH Terms] OR Diet Therapies[Title/Ab-
stract] OR “dietary supplements”[MeSH Terms] OR Dietary 
Supplement[Title/Abstract] OR Food Supplementation[Title/
Abstract] OR Dietary Supplementation[Title/Abstract] OR Di-
etary Supplementations[Title/Abstract] OR Supplemented 
Food[Title/Abstract] OR Supplemented Foods[Title/Abstract] OR 
Food Supplements[Title/Abstract] OR Food Supplement[Title/
Abstract] OR “enteral nutrition”[MeSH Terms] OR Enteral 
Feeding[Title/Abstract] OR Tube Feeding[Title/Abstract] OR “food, 
formulated”[MeSH Terms] OR Formulated Food[Title/Abstract] 
OR Formulated Foods[Title/Abstract] OR Synthetic Diet[Title/
Abstract] OR Dietary Formulations[Title/Abstract] OR Dietary 
Formulation[Title/Abstract] OR Chemically Defined Diet[Title/
Abstract] OR Chemically Defined Diets[Title/Abstract] OR Ele-
mental Diet[Title/Abstract] OR Elemental Diets[Title/Abstract] OR 
(“nutritional support”[MeSH Terms] OR “nutrition therapy”[MeSH 
Terms]) OR Medical Nutrition Therapy[Title/Abstract] OR “nutri-
tional support”[MeSH Terms] OR Artificial Feeding[Title/Abstract]
#3 (((((((Clinical Trial[Publication Type]) OR Randomized[Title/Ab-
stract]) OR Placebo[Title/Abstract]) OR Clinical Trial as Topic[MeSH 
Terms]) OR Randomly[Title/Abstract]) OR Trial[Title/Abstract]) OR 
Groups[Title/Abstract])
#1 AND #2 AND #3
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MEDINE/PUBMED - 66
EMBASE - 100
COCHRANE - 58
WEB OF SCIENCE - 124
CINAHL - 69
LILACS - 0
Additional
records
identified other
sources - 15
Duplicated articles exclued - 156
Studies Selected - 432 Studies Excluded
Articles completely
excluded - 22
3 studies did not meet
the objectives of
the study
One pilot study
Articles completely evaluated conforming
to the eligibility criteria - 32
Studies included in the qualitative analysis - 10
5 non-randomized
studies
13  studies did not
broach the subject
of PU healing
Legend: + 'low risk of bias' (low risk of bias); - High risk of bias' (high risk of bias); ? 'uncertain risk of bias' (unclear risk of bias).
Figure 2 – Individual assessment of the methodological quality of the studies included in the systematic review - Curitiba, PR, 2013.
Figure 1 - Flowchart of identification, selection and inclusion of studies - Curitiba, 2013.
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Chart 2 presents selected studies and related references, 
year of publication, country, design and number of patients. 
Chart 3 presents the list of studies as the intervention and 
the number of participants in the experimental group and 
control, valuation and follow-up. It is noted that the opera-
tions contemplated supplements such as arginine, vitamin 
C, collagen, ornithine alpha-ketoglutarate (OKG), zinc 
sulfate, hydrolyzed collagen and mixed nutritional supple-
ments. Only two studies (E412, E419) had the same inter-
vention (vitamin C).
continued...
Chart 2 – Selected studies according to the reference year, country, design and number of patients - Curitiba, 2013.
Study Reference Year/Country Design/number of patients
E5
Leigh B, Desneves K, Rafferty J, Pearce L, King S, Woodward MC, et al. 
The effect of different doses of an arginine-containing supplement on the 
healing of Pressure ulcers. J Wound Care. 2012; 21(3):150-6.
2012
Australia
Randomized Clinical  
Trial /n=23
E10
Ohura T, Nakajo T, Okada S, Omura K, Adachi K. Evaluation of effects of 
nutrition intervention on healing of pressure ulcers and nutritional states 
(randomized controlled trial). Wound Repair Regen. 2011;9(3):330-6.
2011
Japan
Multicenter, Randomized 
Clinical Trial /n=30
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...continuation
Study Reference Year/Country Design/number of patients
E32
Lee SK, Posthauer ME, Dorner B, Redovian V, Maloney MJ. Pressure 
ulcer healing with a concentrated, fortified, collagen protein hydroly-
sate supplement: a randomized controlled trial. Adv Skin Wound Care. 
2006;19(2):92-6.
2006
United States of 
America
Multicenter, Controlled, 
Randomized Clinical Trial/n=89
E90
Meaume S, Kerihuel JC, Constans T, Teot L, Lerebours E, Kern J, et al. Ef-
ficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers 
in elderly patients: results of a randomized controlled trial. J Nutr Health 
Aging. 2009; 13(7):623-30.
2009
Bulgaria, France, 
Germany, Italy, 
Romania, Spain
Multicenter, Randomized Clinical 
Trial/n=160
E412 Riet GT, Kessels AG, Knipschild P. Randomised clinical trial of ultrasound treatment for pressure ulcers. BMJ. 1995; 310(6986):1040-1.
1995
Holland
Multicenter, Blind, Randomized 
Clinical Trial/n=88
E418 Norris JR, Reynolds RE. The effect of oral zinc sulfate therapy on decubi-tus ulcers. J Am Geriatr Soc. 1971; 19(9):793-7.
1971
United States of 
America
Randomized Clinical Trial 
Crossover/n=14
E419
Taylor TV, Rimmer S, Day B, Butcher J, Dymock IW. Ascorbic 
acid supplementation in the treatment of pressure-sores. Lancet. 
1974;304(7880):544-6.
1974
United States of 
America
Double-Blind, Controlled, 
Randomized Clinical Trial /n=20
E424
Desneves KJ, Todorovic BE, Cassar A, Crowe TC. Treatment with supple-
mentary arginine, vitamin C and zinc in patients with pressure ulcers: a 
randomised controlled trial. Clin Nutr. 2005; 24(6):979-87.
2005
Australia Randomized Clinical Trial /n=16
E425
Van Anholt RD, Sobotka L, Meijer EP, Heyman H, Groen HW, Topinková 
E, Van Leen M, et al. Specific nutritional support accelerates pressure 
ulcer healing and reduces wound care intensity in non-malnourished pa-
tients. Nutrition. 2010; 26(9):867-72.
2010
Czech Republic, 
Belgium, 
Holland, 
Curacao
Multicenter, Randomized Clinical 
Trial/n=43
E426
Cereda E, Gini A, Pedrolli C, Vanotti A. Disease-Specific, Versus Standard, 
Nutritional Support for the Treatment of Pressure Ulcers in Institutional-
ized Older Adults: a randomized controlled trial. Am Geriatr Soc. 2009; 
57(8):1395-402.
2009
Italy
Controlled, Randomized Clinical 
Trial/n=38
Chart 3 - Selected studies according to the intervention in the experimental and control groups, number of participants in the experi-
mental group and control, evaluation and follow-up - Curitiba, 2013.
Study Intervention Experiment (N)
Control 
(N)
Evaluation 
Method Follow-up time
E10
Mixed nutritional supplements
Specialized formula containing protein, carbohydrates, fats and 
micronutrients in calculated amount based on energy expendi-
ture and stress factor vs specialized formula containing protein, 
carbohydrates, fats and micronutrients maintaining normal 
caloric intake;
21 29 DESIGN scale; 12 weeks
E424
Standard hospital diet (diet A) vs standard hospital diet and 
specialized formula with high protein content (diet B) vs stan-
dard hospital diet and specialized formula with high protein, 
arginine, zinc and vitamin C (diet C);
Diet B – 5
Diet C – 5 Diet A – 6 PUSH tool; 3 weeks
E425
Specialized formula with high energy content and enriched 
with arginine, vitamin C, vitamin A, vitamin E, carotenoids, 
zinc, selenium, copper, and folic acid vs placebo;
22 21 PUSH tool; 8 weeks
E426 Specialized formula enriched with arginine, zinc and vitamin C vs standard hospital diet or standard enteral formula; 13 15 PUSH tool; 12 weeks
E5 Arginine4.5 g of arginine vs 9 g of arginine; 12 11 PUSH tool; 3 weeks
E32 Hydrolyzed collagenHydrolyzed collagen vs Placebo; 44 27 PUSH tool; 8 weeks
E90 Ornithine alpha-ketoglutarateOrnithine alpha-ketoglutarate (OKG) vs Placebo; 85 75
Verification of 
the area; 6 weeks
E412
Vitamin C
Vitamin C (500 mg two times per day) vs Vitamin C (10 mg two 
times per day);
38 29
Verification of 
the area; and 
photography;
12 weeks
E419 Vitamin C (500 mg two times per day) vs Placebo (two times per day); 10 10
Subjective 
evaluation of 
a researcher; 
Verification of 
the area; and 
photography;
4 weeks
continued...
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Study Intervention Experiment (N)
Control 
(N)
Evaluation 
Method Follow-up time
E418 Zinc SulfateZinc sulfate vs Placebo; 10 10
Verification 
of the volume 
of the lesion 
through 
alginate 
(jeltrate);
24 weeks 
(permutation with 
12)
Four studies (E10, E424, E425, E426) evaluated the 
use of mixed nutritional supplements. In the study E10, 
interaction between the two groups (intervention and con-
trol) as the size of the PU and the intervention period was 
significant (p <0.001). There was a significant reduction in 
wound size from the first day of the intervention period (p 
= 0.05). The E424 study that evaluated the diets A, B and C, 
obtained that: Diet C showed a significant improvement of 
the initial PUSH tool score (9.4 ± 1.2); and the PUSH tool 
score in the third week was significantly lower compared 
to diets A and B (7.0 ± 1.5 and 6.0 ± 1.2, p <0.05). The 
patients showed an approximate 2.5 times greater improve-
ment in healing of the PU after three weeks in comparison 
with the other two groups. Diet A (control) showed a slight 
improvement in the healing of PU in the third week (8.7 ± 
1.0 vs. 7.0 ± 1.5; Week 0 and 3, respectively; p <0.05), and 
for Diet B there were no significant changes in PUSH tool 
score in the three weeks.
In the study E425, reduction in the size of the PU in the 
experimental group differed significantly from the control 
group during the eight-week period (p=0.006, treatment by 
time, p=0.016, treatment by time2, repeated-measures mixed 
models [RMMM]). PU in the experimental group were 
significantly lower compared with the initial assessment 
from the third week (p=0.019) and in the following weeks 
(p=0.012). In the control group, the PU were significantly 
lower compared with the initial assessment from the fifth 
week (p=0.019), and in subsequent weeks (p=0.008). The 
PUSH tool score improved significantly in the experimen-
tal group compared with the control group (p=0.011, treat-
ment by time, p=0.033, treatment by time2, RMMM). The 
types of tissues differed significantly between treatments 
after four weeks, there were fewer PU identified with 'gran-
ulation tissue' or 'necrotic tissue' and more PU identified 
as 'closed' or 'epithelial tissue' in the experimental group 
compared to the control group (p=0.037), demonstrating 
good progress of healing and the presence of complete heal-
ing of the lesions. The PUSH tool instrument subscores 
related to the size of the PU and amount of exudate did not 
differ significantly between groups. However, the decrease 
in the number of dressings (experimental group) differed 
significantly from the control group throughout the period 
of eight weeks (p = 0.003, treatment by time; p=0.045, treat-
ment by time2, RMMM, post hoc). Thus, it is inferred that 
the general health condition of the PU improved; for in-
stance the exudate and presence of devitalized tissues.
The differences between the interventions in E426 study 
became statistically significant in the PUSH tool score in 
week 12 (p <0.05) and PU area in week 8 (p<0.05). The 
...continuation
experimental group showed a significantly greater reduc-
tion in average with regard to the area of PU (57% vs. 33% 
at 8 weeks, p<0.02; 72% vs 45% at 12 weeks, p<0.005). 
The provision of adequate amounts of energy and protein 
was shown to be effective in improving the healing of PU 
(p<0.001) for both groups.
The E5 study evaluated the use of arginine in the heal-
ing of PU and obtained a significant difference in PUSH 
tool score declining over time (p<0.001). There was no dif-
ference in healing rates between the groups (p=0.991).
The E32 study evaluated the hydrolyzed collagen and 
identified that changing the PUSH tool score in eight 
weeks was 3.22 ± 4.11 in the control group and 3.55 ± 4.66 
(p<0.05) in the experimental group. The PUSH tool scores 
decreased in all patients during the intervention period, 
however the experimental group had approximately twice 
the healing rate compared to the control group. The experi-
mental group had greater reduction in PUSH tool scores 
compared to the control group (60% vs 48%, p<0.05).
The ornithine alpha-ketoglutarate was evaluated by 
E90 studies and the PU subgroup with area ≤ 8 cm2 showed 
an absolute decrease in PU area in the sixth week signifi-
cantly higher in the experimental group compared with the 
control group (-2.3 ± 4.2 cm2 vs. -1.7 ± 1.7 cm2, p=0.006). 
There was a tendency to a higher proportion of wounds 
that reached a higher regression to 90% in six weeks in the 
experimental group (23.4% vs 13.0%) (OR = 0.49; 95% CI 
[0.16 to 1.46]. The healing rate was higher in the experi-
mental group compared to the control group (-0.07 ± 0.11 
cm2/day vs. 0.04 ± 0.08 cm2/day; p=0.007). In subgroup 
area > 8 cm2 there were no differences between the groups 
regarding the absolute decrease in the area, proportion of 
regression and PU healing rate. There was no difference in 
healing rates.
Two studies assessed vitamin C (E412, E419). The 
E412 study in the analysis by intention to treat (ITT), the 
absolute healing rate in the experimental group was 0.21 
and 0.27 cm2/week in the control group (90% CI). The 
average reduction in the volume of PU was 0 ml/week in 
the experimental group and 0.20 ml/week in the control 
group (90% CI). The average 'clinical change' (healing rate, 
reduced surface and volume) was scored on a scale from 
-100 to + 100%, and the experimental group showed im-
provements of 17.89% per week and 26.08% per week in 
the control group. In the per-protocol analysis, 67 patients 
were included; the absolute healing rate in the experimental 
group (n=35) was 0.23 and was 0.27 cm2/week in the con-
trol group (n=28) (90% CI). The average reduction in the 
volume of PU was 0.05 ml/week in the experimental group 
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and 0.11 ml/week in the control group (90% CI). The aver-
age 'clinical change' in the experimental group was 18.79% 
per week and 29.50% per week in the control group.
In the E419 study, the experimental group showed a 
significant reduction in the PU area of 84% (p<0.005), com-
pared to 42.7% (p<0.001) in the control group. The mean 
healing rates were 2.47 cm2 and 1.45 cm2 per week in the 
treated and untreated groups, respectively.
Zinc sulfate was assessed in the E418 study. For the 
ten participants who received the intervention, there was a 
change in the PU with regard to the average volume of 10 
ml (± 9 ml), the ten patients who had received placebo had a 
change in average volume of 6.0 mL (17.5 ml ±), the results 
were not statistically significant.
DISCUSSION
Considering that proper nutrition is related to the 
healing process, the objective of this SR was to evaluate 
the effectiveness of ENT as a treatment in the PU healing 
process for adults and the elderly. For this outcome, the 
results of the included studies show that ENT helps the 
healing of PU, but sufficient evidence was not found to 
confirm this finding.
553 patients were randomized from selected studies, and 
of these 488 were included in the analyzes of the data.
Regarding the ‘complete healing of PU’, five studies 
reported that 39 PU achieved this outcome (E10, E90, 
E425, E426, E419). A greater proportion of PU healed in 
the experimental groups (61.5%). For the subgroup 'mixed 
nutritional supplements' (E10; E425; E426) there were 16 
PU healed in experimental groups (28.5%; N=56) and 9 in 
control (13%, N=65), tracking time of 8 to 12 weeks.
This agrees with the finding of this study(23), an open 
multicenter trial which included 245 patients and evalu-
ated the effects of mixed nutritional supplements (protein, 
arginine, vitamin C, vitamin E, and other micronutrients 
- Cubitan®), and obtained 65 PU (27%) healed in nine 
weeks. The systematic review(24) used the following terms 
for limiting the use of outcomes: ‘reduction in wound size’ 
and ‘healing rate’ as a substitute for ‘complete healing' for 
the included studies, and the lack of homogeneity in the 
outcomes made it difficult to compare studies.
As for the outcome ‘partial healing’ for the subgroup 
‘mixed nutritional supplements’, the groups that received 
the intervention showed a decrease in depth and area of the 
lesion, as well as improved healing rates compared to the 
control groups. It is inferred that ENT enriched with pro-
teins and micronutrients favor the PU healing process (E10, 
E424, E425, E426). In line with this finding, a study(23) 
found a significant reduction in the area of ulcers (1580 ± 
3743 mm2 to 743 mm2 ± 1809), representing 53% reduction 
in nine weeks (p<0.0001). A prospective study(25) conducted 
with 39 patients which used a mixed nutritional supple-
ment (supplement rich in protein, enriched with arginine, 
vitamin C and zinc), and after three weeks of intervention 
showed significant reduction in the area of PU (23.6 cm2 
to 19.2 cm2) (p<0.001), representing a reduction of 29%. 
Still, national guideline recommends nutrition therapy for 
PU patients using nutrient immune-modulating formulas 
and higher protein content in the treating patients with 
PU, with a high degree of recommendation and strength 
of evidence (A)(26).
For the ‘arginine’ subgroup, only one study evaluated this 
nutrient alone. There were no significant differences in the 
healing rate between the experimental and control groups, 
so it is suggested that a dose of 4.5g of arginine per day can 
promote effective similar healing compared to a dose of 9g 
(E5). It is noteworthy that of the included studies, three had 
arginine in the formula compositions (E424, E425, E426). 
An observational study(27) evaluated the rate and the time 
for PU healing in 18 participants who received nutritional 
therapy with 9g of arginine (Arginaid®, Nestlé Nutrition®) 
compared to a historical control with 17 participants. We 
identified a total of 26 PU healed in the historical control 
group and 30 PU in the 18 patients in the experimental 
group. In the experimental group, the healing time was 
found to be twice as fast compared to the control (10.5 ± 
1.3 weeks vs 21 ± 3.7 weeks; p=0.006). Therefore, this study 
suggests the benefit of supplementation with 9g of arginine 
for PU healing.
The results deviated for the ‘vitamin C’ subgroup. Given 
the heterogeneity of the included studies, it is concluded 
that there is no evidence on the benefits of vitamin C sup-
plementation in the healing of PU (E412, E419). To con-
firm these findings, four other SRs that evaluated the effects 
of vitamin C supplementation in PU healing were included 
in the same studies of this review and concluded that due 
to the scarcity of scientific production and methodological 
rigor, the role of vitamin C remains uncertain in the heal-
ing of PU (16,18,24,). It is noteworthy that four other studies 
included in this review had vitamin C in the compositions 
of formulas (E10; E424: E425, E426).
The patients who received the ‘zinc sulfate’ interven-
tion showed a reduction in the volume of the lesion, how-
ever there was no statistical significance and only three 
patients completed the study (E418). Corroborating this 
data, six RCTs were included in a SR(28) in order to de-
termine the effectiveness of zinc sulfate supplementation 
promote the healing of venous and arterial ulcers, noting 
that there is no evidence to say that zinc sulfate supple-
mentation promotes healing.
A critical review(29) on the effects of zinc supplemen-
tation in wound healing was conducted in the scientific 
literature and found that zinc significantly participates in 
the healing process, however there is evidence to support 
the indication of supplementation. The included studies 
were considered old, with small samples, short follow-up, 
high rate of follow-up losses, and low methodological 
quality. Thus, we highlight the need for studies with rig-
orous methodology.
Regarding the use of ‘mixed nutritional supplements’, al-
though there is no evidence that supplementation with vita-
mins and minerals assist in the healing of PU, supplementa-
tion is recommended when there is suspicion of deficiencies(3).
For the ‘ornithine alpha-ketoglutarate’, there were 
only statistical differences for the subgroup ≤ 8 cm2, the 
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experimental group showed greater reduction in total area 
compared to the control. The study suggests that supple-
mentation with OKG has benefits in reducing the PU area 
with an area less than or equal to 8 cm2, accelerating the 
healing process (E90). This data corroborates the RCT with 
47 participants which examined the effectiveness of OKG 
compared with isonitrogenous control in the healing of se-
verely burned patients. It was found that the healing time 
of wounds in patients receiving OKG was lower compared 
to the control (60 ± 7 vs 90 ± 12 days; p <0.05)(30).
For ‘hydrolyzed collagen’, the experimental group had ap-
proximately twice the healing rate compared to the control 
group and obtained greater reduction in PUSH tool score in 
eight weeks (60% vs 48%, p<0.05). The study suggests that 
supplementation with hydrolyzed collagen promotes PU 
healing (E32). Other studies that have evaluated the effects 
of ENT with hydrolyzed collagen in PU and other types of 
wounds were not identified; the authors of the study have 
proposed to ignore studies that address this issue (E32).
Regarding the ‘reduction of devitalized tissue’, only 
one study in the ‘mixed nutritional supplements’ subgroup 
(E425) evaluated this outcome. There was a significant de-
crease in the number of bandages in the experimental group 
compared to the control group, so it is inferred that it im-
proves the general health of the PU with regards to exudate 
and presence of devitalized tissues. Also, two studies(23,25) 
have analyzed the outcome “reduction of exudate” and found 
a significant reduction in the amount of exudate in three to 
nine weeks, respectively (p=0.012; p<0.0001). One study(25) 
found a significant reduction of necrotic tissue (p=0.001).
Prior to the preparation of this review, searches were 
conducted in order to identify other SR that addressed the 
ENT as a treatment for PU. Three were found, however 
these were not restricted to ENT, and/or did not perform 
extensive searches in databases, and/or had not been prop-
erly updated. The first review(16) included eight studies that 
dated from 1971 to 1995, the second(17) had four from 1990 
to 2002, and the third(18) had seven studies from 1971 to 
2006. In this review ten studies published between 1971 to 
2012 were included, of which five had more recent publica-
tion years to the other reviews.
In this review, the included studies were heterogeneous 
in relation to patients (surgical, residents of long term care 
facilities for the elderly - ILPIs, eligibility criteria), the type 
of intervention, sample and follow-up. It is inferred that the 
interpretation of the results of the studies should be done 
with caution given the sample size and follow-up losses. The 
heterogeneity between the studies prevented the combina-
tion and comparison of the results, and thus were consid-
ered inadequate to perform meta-analysis and to detect the 
effects of nutritional interventions.
Among the limitations of SR, RCT showed no adequate 
description of the methodology with relevant and clear in-
formation, meaning a detailed description of the methods 
of allocation concealment, random sequence generation, 
and use of a double-blind method. Similar to this review, 
a SR(25) that evaluated the efficacy and safety of treatment 
strategies for adults with pressure ulcers published in 2013 
included 11 RCTs, three of which were considered of good 
quality, two moderate quality and six of poor quality. To 
meet with the present review, limitations were reported as: 
low methodological quality; small samples, which limits the 
detection of statistically significant differences; differences 
in the population of patients according to the characteristics 
of ulcers (location and stage), and comparison interventions 
(placebo or standard treatment)(25).
Another limitation was the risk of bias assessment, only 
two studies (E32, E90) had low risk of bias for all areas 
evaluated in the "Cochrane Collaboration tool for assess-
ing the risk of bias in randomized clinical trials". The other 
RCT did not show adequate description of the methodol-
ogy, such as a detailed description of the methods of al-
location concealment, random sequence generation, and 
using double-blind method. However, it is not possible to 
precisely state that the absence of such data indicates that 
the study was not conducted properly; considering that 
sometimes data is omitted due to the rules of publication 
required by magazines such as a page limit for the study. 
RCTs included were conducted with small samples, a fact 
that complicates detecting the effects of interventions and 
significant differences between the groups.
The different components included in ENT: arginine 
(E5), vitamin C (E412, E419), hydrolyzed collagen (E32), 
OKG (E90), zinc sulfate (E418) and mixed nutritional 
supplements (E10; E424; E425; E426). Most of the stud-
ies had mixed nutritional supplements as an intervention 
which makes it impossible to check the effects of the com-
ponents alone, or as a group for statistical analysis in the SR.
The studies differed with regard to data analysis, there 
were only graphs/charts and a lack of absolute data, ob-
structing the critical analysis and grouping of studies.
Thus, there is no way to confirm that ENT favors PU 
healing in adults and the elderly, but this review shows ad-
vances with a higher confidence index and less bias risk 
because only RCT were included, an extensive search in 
various database data was conducted, there was a strict and 
predefined methodology, relevant research was selected 
and critically-assessed, data was collected and analyzed 
from studies, providing important information for clinical 
decision-making.
CONCLUSION
From the individual studies, it appears that the ENT 
with protein and micronutrient formulas can provide ben-
efits to the healing process as well as the calculation of the 
optimal dosage with regard to basal energy expenditure. 
However, there is insufficient evidence and meta-analysis 
was not possible to assert that ENT promotes PU healing. 
However, the importance of nutritional intervention in mal-
nourished patients and those with PU is undeniable, done 
by the evaluation of multiprofessional staff and a special-
ized nutritional team. Thus, it cannot be determined which 
nutritional components should be adopted for treatment of 
PU until new RCTs are carried out. It is suggested that the 
clinical practice remains supported by the guidelines on PU 
and ENT treatment.
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Through this study, two gaps present in scientific produc-
tion were found. The first was observed regarding the effec-
tiveness of ENT with only vitamin C in the PU healing pro-
cess, considering that the last RCT identified concerning this 
subject was from 1995. A second gap investigated concerns 
hydrolyzed collagen that although has shown favorable re-
sults and indicates that its action promotes PU healing, other 
studies that evaluated the effectiveness of supplementation 
for PU and other types of wounds were not found. Therefore, 
research that addresses the action of these two nutrients needs 
to be performed. Further research with a larger number of 
patients and with adequate methodology are necessary to 
obtain evidence to assess the impact of nutrition on ulcers.
Given the scarcity of data from quality RCTs to indicate 
the use of ENT and the composition of the formulas, it 
is appropriate to conduct new studies to be incorporated 
into this review in order to establish the safety, benefits and 
greater certainty regarding the use of ENT for treatment 
of PU. It is suggested to conduct randomized clinical tri-
als with rigorous methodological description and sustained 
in concrete recommendations in the literature. They also 
need to be conducted with larger samples, an assessment of 
isolated nutritional components, with results described in 
detail and providing absolute data.
RESUMO
Objetivo: Avaliar a efetividade da terapia nutricional enteral no processo de cicatrização das úlceras por pressão em adultos e idosos. 
Método: Revisão sistemática cujos estudos foram identificados por meio das bases de dados Cochrane, MEDLINE/PubMed, SciELO, 
LILACS, EMBASE, CINAHL, Web of Science, e por busca manual. Incluíram-se ensaios clínicos randomizados, sem delimitação de 
período e idioma da publicação, que abordaram pacientes adultos e idosos portadores de úlceras por pressão, em tratamento comparativo 
entre terapia nutricional enteral e placebo ou entre terapia nutricional enteral com diferentes composições e dosagens. Resultados: 
Foram incluídos dez estudos, que contemplaram diferentes intervenções. Apontaram maior número de úlceras por pressão cicatrizadas 
nos grupos que receberam a intervenção. Os estudos incluídos foram heterogêneos em relação aos pacientes, ao tipo de intervenção, 
à amostra e ao tempo de seguimento, aspectos que inviabilizaram a metanálise. Conclusão: Embora a terapia nutricional enteral 
demonstre favorecer a cicatrização de úlcera por pressão, não foram encontradas evidências suficientes para confirmar essa hipótese.
DESCRITORES
Úlcera por Pressão; Terapia Nutricional; Cicatrização; Revisão.
RESUMEN
Objetivo: Evaluar la efectividad de la terapia de nutrición enteral en el proceso de cicatrización de las úlceras por presión en adultos 
y ancianos. Método: Revisión sistemática cuyos estudios fueron identificados por medio de las bases de datos Cochrane, MEDLINE/
PubMed, SciELO, LILACS, EMBASE, CINAHL, Web of Science, y por búsqueda manual. Se incluyeron ensayos clínicos randomizados, 
sin delimitación de período e idioma de la publicación, que abordaron a pacientes adultos y ancianos portadores de úlceras por presión, 
en tratamiento comparativo entre terapia de nutrición enteral y placebo o entre terapia de nutrición enteral con distintas composiciones 
y dosificaciones. Resultados: Fueron incluidos diez estudios, que contemplaron diferentes intervenciones. Señalaron mayor cantidad de 
úlceras por presión cicatrizadas en los grupos que recibieron la intervención. Los estudios incluidos fueron heterogéneos con relación 
a los pacientes, la clase de intervención, la muestra y el tiempo de seguimiento, y los aspectos que hicieron inviable el metanálisis. 
Conclusión: Aunque la terapia de nutrición enteral demuestre favorecer la cicatrización de la úlcera por presión, no se encontraron 
evidencias suficientes para confirmar dicha hipótesis.
DESCRIPTORES
Úlcera por Presión; Terapia Nutricional; Cicatrización de Heridas; Revisión.
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